Home › Mantle Cell Lymphoma › Washington › Seattle

Pag-aaral pangklinika para sa Mantle Cell Lymphoma sa Seattle, WA

Isang pag-aaral para sa Mantle Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Nagre-recruitPhase 1/2

Research Site, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06542250

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Fred Hutchinson Cancer Research Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Nagre-recruitPhase 1/2

Fred Hutchinson Cancer Research Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06697184

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Swedish Cancer Institute (SCI), Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT07121946

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

Fred Hutch/University of Washington Cancer Consortium, Seattle

6 Months · Lahat ng kasarian · Na-update May 29, 2026 · NCT04195633

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

Nagre-recruitPhase 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT06839053

Study of SGR-1505 in Mature B-Cell Neoplasms

Nagre-recruitPhase 1

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Nagre-recruitPhase 1

Providence Swedish Cancer Institute, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 20, 2025 · NCT05370430

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Seattle

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

Swedish Cancer Institute, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Pag-aaral para sa Mantle Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.